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Abstract
Background: Optic neuritis is an acute, demyelinating neuropathy of the optic nerve often representing the first
appreciable symptom of multiple sclerosis. Wallerian degeneration of irreversibly damaged optic nerve axons leads
to death of retinal ganglion cells, which is the cause of permanent visual impairment. Although the specific
mechanisms responsible for triggering these events are unknown, it has been suggested that a key pathological
factor is the activation of immune-inflammatory processes secondary to leukocyte infiltration. However, to date,
there is no conclusive evidence to support such a causal role for infiltrating peripheral immune cells in the
etiopathology of optic neuritis.
Methods: To dissect the contribution of the peripheral immune-inflammatory response versus the CNS-specific
inflammatory response in the development of optic neuritis, we analyzed optic nerve and retinal ganglion cells
pathology in wild-type and GFAP-IκBα-dn transgenic mice, where NF-κB is selectively inactivated in astrocytes,
following induction of EAE.
Results: We found that, in wild-type mice, axonal demyelination in the optic nerve occurred as early as 8 days post
induction of EAE, prior to the earliest signs of leukocyte infiltration (20 days post induction). On the contrary,
GFAP-IκBα-dn mice were significantly protected and showed a nearly complete prevention of axonal demyelination,
as well as a drastic attenuation in retinal ganglion cell death. This correlated with a decrease in the expression of
pro-inflammatory cytokines, chemokines, adhesion molecules, as well as a prevention of NAD(P)H oxidase subunit
upregulation.
Conclusions: Our results provide evidence that astrocytes, not infiltrating immune cells, play a key role in the
development of optic neuritis and that astrocyte-mediated neurotoxicity is dependent on activation of a
transcriptional program regulated by NF-κB. Hence, interventions targeting the NF-κB transcription factor in
astroglia may be of therapeutic value in the treatment of optic neuritis associated with multiple sclerosis.
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Introduction
Optic neuritis (ON) is the earliest manifestation of multiple
sclerosis (MS) occurring in approximately 20% of patients
[1]. It is characterized by unilateral, painful loss of vision in
the absence of neurological or systemic symptoms [1].
Hallmark of the pathology is axonal injury associated with
demyelination, which leads to Wallerian degeneration of
the optic nerve and, ultimately, delayed death of retinal
ganglion cells (RGCs) [2,3]. Although the specific mechan-
isms responsible for triggering axonal injury and demyelin-
ation in ON are unknown, it has been suggested that a key
event is the activation of immune-inflammatory processes
secondary to leukocyte infiltration into the optic nerve
[4-6]. Indeed, studies in mice induced with experimental
autoimmune encephalomyelitis (EAE), a model of MS,
have shown that ON is accompanied by presence of
macrophages [7] and T cells [8] in the optic nerve, and
strategies aimed at preventing the recruitment of such
immune cells can reduce axonal and myelin damage [7,9].
Nevertheless, there is no conclusive evidence to support a
causal role for infiltrating peripheral immune cells in the
etiopathology of ON, since no exhaustive studies have been
conducted to profile and compare the exact timing of
axonal damage and immune cell infiltration in the optic
nerve. A mounting body of evidence has underscored that
axonal injury in MS and EAE can occur early on in the
disease process, even prior to the appearance of clinical
symptoms and in the absence of inflammatory infiltrates
into the brain or spinal cord [10,11]. Therefore, it is plaus-
ible that axonal damage in the optic nerve could also initi-
ate early and independently of immune cell activation.
Along with this concept, Howell and colleagues demon-
strated that, both in MS (in normal appearing white mat-
ter) and EAE, the disruption of the axon/oligodendrocyte
association at nodal and paranodal domains is associated
with axonal damage and it occurs in parallel with local
microglia activation before the infiltration of immune cells
[10]. Microglia activation has been shown to occur as early
as 7 days after induction of EAE in spinal cord and brain
parenchyma, well ahead of leukocyte infiltration [12]. This
suggests that resident cells of the central nervous system
(CNS) which have immune-inflammatory competence,
namely microglia, may play an active role in the early
development and progression of axonal injury in MS and
ON. In addition to microglia, it has been shown that astro-
cytic responses contribute to EAE pathology, similarly to
other neurodegenerative conditions. Indeed, evidence of
axonal injury has been reported in the pre-clinical phase of
EAE prior to measurable T cell entry into the CNS paren-
chyma and in coincidence with astrocytic activation [13].
In our own work we demonstrated that by inhibiting the
transcription factor NF-κB selectively in astrocytes with a
genetic approach (GFAP-IκBα-dn mice) mice are protected
from MOG-induced EAE. This was due to the suppression
of astrocyte-dependent inflammation, providing a direct
demonstration of the crucial role of astrocytes in the devel-
opment and progression of the disease [14]. In order to
dissect the contribution of CNS-specific versus peripheral
immune-inflammatory response in ON, in the present
study we compared optic nerve and RGC pathology in
wild-type (WT) and GFAP-IκBα-dn mice induced with
EAE. We found that, in WT mice, significant axonal and
myelin damage in the optic nerve occurred as early as
8 days post induction (dpi) of EAE, prior to even the earli-
est signs of leukocyte infiltration, that became evident only
at 11 dpi (only a few sparse cells) in our experimental
paradigm. GFAP-IκBα-dn mice, however, were significantly
protected and showed a nearly complete prevention of
axonal demyelination, as well as a drastic attenuation of
RGC death. This correlated with a decrease in the expres-
sion of pro-inflammatory cytokines, chemokines, adhesion
molecules, as well as suppression of NAD(P)H oxidase
(Cybb/NOX2 and Ncf1 subunits). Combined, these data
suggest that NF-κB-dependent events activated in astro-
cytes in the early stages of disease are key determinants in
the initiation and progression of ON.
Materials and methods
Mice
Experiments were performed according to protocols
approved by the Institutional Animal Care and Use
Committee of the University of Miami. GFAP-IκBα
dominant negative (GFAP-IκBα-dn) mice were generated
in the Transgenic Core Facility of the University of
Miami as previously described [15], and extensively
characterized under physiological conditions and in vari-
ous models of neurodegenerative diseases [14,16-22].
GFAP-IκBα-dn mice are designed to expresses a trun-
cated form of the inhibitor of κB alpha (IκBα) under the
control of the glial fibrillary acidic protein (GFAP) pro-
moter, resulting in functional inactivation of the NF-κB
classical pathway in astrocytes and in GFAP-expressing
non-myelinating Schwann cells [15,18,20]. All behav-
ioral, biochemical, and immunological analyses of
GFAP-IκBα-dn mice have been previously published
[14-18,20]. All mice used in the present study were 2- to
4-month-old females obtained by breeding heterozygous
GFAP-IκBα-dn males with WT females. WT littermates
were used as controls. Animals were housed in a 12-h
light/dark cycle in a virus/antigen free facility with
controlled temperature and humidity and provided with
water and food ad libitum.
Induction of EAE
Active EAE was induced with MOG(35–55) peptide as
previously described [23]. Clinical signs of EAE were
assessed daily using a standard scale of 0 to 6 as follows:
0, no clinical signs; 1, loss of tail tone; 2, flaccid tail; 3,
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complete hind limb paralysis; 4, complete forelimb
paralysis; 5, moribund; 6, dead. Mice were considered at
onset of EAE when they reached a score of 2 or more
for at least 2 consecutive days.
Total RNA isolation and real-time PCR
After perfusion of the mice with cold PBS, optic nerves
were quickly dissected out, homogenized in lysis buffer,
frozen instantly and stored in liquid nitrogen until fur-
ther processing. Prior to RNA extraction, optic nerves
were subjected to 20 freeze-thaw cycles. Total RNA was
extracted with a resin spin-column system (Absolutely
RNA Nanoprep Kit, Stratagene) and reverse transcribed
to synthesize cDNA (Reverse Transcription System, Pro-
mega). Real-time PCR was performed in the Rotor-Gene
6000 Cycler (Corbett Research) using SYBR GREEN
PCR MasterMix (Qiagen) and gene-specific primers
(Table 1). Relative expression was calculated by compari-
son with a standard curve after normalization to the
housekeeping gene β-actin.
Immunohistochemistry
Mice were transcardially perfused with 4% paraformalde-
hyde in PBS. Eyes were enucleated and the optic nerves
removed. After washing in PBS, optic nerves were embed-
ded in OCT medium, cryosectioned at a 10 μm thickness
and stored at −20°C. Prior to immunostaining, sections
were thawed at room temperature, post-fixed for 15 min
in 4% paraformaldehyde in PBS, washed and permeabilized
in 0.3% Triton X-100 in PBS for 30 min. Tissues were
blocked with PBS containing 0.15% Tween 20, 2% bovine
serum albumin (BSA), and 5% serum (either goat or don-
key to match the secondary antibody) for 30 min at room
temperature. Sections were then incubated with primary
antibodies (rabbit anti-GFAP, 1:1,000, Dako; rat anti-
CD45, 1:250, Invitrogen; goat anti-p47phox, 1:200, Santa
Cruz) in blocking solution, overnight at 4°C. After thor-
ough washing in PBS, sections were incubated with
species-specific fluorescent secondary antibodies for 1.5 h
at room temperature. Control sections were incubated
with secondary antibody alone. Finally, sections were
cover-slipped with Vectashield (Vector) fluorescent
mounting medium containing DAPI. Imaging was per-
formed with a Leica TSL AOBS SP5 confocal microscope
(Leica Microsystems).
P-phenylenediamine (PPD) staining of the optic nerve and
quantification of myelinated axons
Mice were transcardially perfused with 4% paraformalde-
hyde in 0.1 M phosphate buffer (pH 7.4). Eyes were enu-
cleated, optic nerves removed and post-fixed in cold 4%
paraformaldehyde/2% glutaraldehyde in 0.1 M phosphate
buffer overnight, followed by 2% osmium tetroxide in
cacodylate buffer (pH 7.4). Tissues were then dehydrated
in alcohol and embedded in epoxy resin. Semi-thin sec-
tions (1 μm thick) were obtained with a Leica Ultracut E
microtome, stained with 1% PPD in methanol-
isopropanol (1:1) for 20 min, rinsed with isopropanol
and cover-slipped. Samples were then examined by light
microscopy on a Zeiss Axioscope and the number of
PPD-stained myelinated axons was estimated using the
software Stereoinvestigator (MicroBrightfield). For this
assessment, six animals/group were used. The analysis
was performed at the Image Analysis Core Facility of the
Miami Project to Cure Paralysis.
NeuN immunohistochemistry in flat mounted retinas and
quantification of RGC numbers
Eyes were enucleated upon euthanasia, incised at the ora
serrata, and immersion-fixed in 4% paraformaldehyde in
PBS (pH 7.4) for 1 h. Retinas were then removed and
cryoprotected overnight in 30% sucrose. Prior to staining,
retinas were subjected to three freeze-thaw cycles, rinsed
three times in PBS, and blocked for 1 h in 0.1 M Tris buffer
(TB) containing 5% donkey serum and 0.1% Triton X-100.
Retinas were then incubated overnight with monoclonal
FITC-conjugated NeuN antibody (Chemicon; dilution
1:300). After three rinses in TB, retinas were flat-mounted,
cover-slipped and imaged using a Leica TSL AOBS SP5
confocal microscope (Leica Microsystems) equipped with
Leica LAS AF software. Quantification of NeuN-positive
RGCs was carried out as follows. To avoid topological
irregularities, stacks of five serial images were collapsed to
generate ‘maximum projections’ (standard feature of the
Table 1 Primers for real-time PCR amplification
Gene Oligonucleotides PCR product size
IL-1β Forward GACCTTCCAGGATGAGGACA 283 bp
Reverse AGGCCACAGGTATTTTGTCG
CCL5 Forward AGCAGCAAGTGCTCCAATCT 280 bp
Reverse ATTTCTTGGGTTTGCTGTGC
CXCL10 Forward GCTGCAACTGCATCCATATC 293 bp
Reverse CACTGGGTAAAGGGGAGTGA
ICAM-1 Forward TGGTGATGCTCAGGTATCCA 273 bp
Reverse CACACTCTCCGGAAACGAAT
TNF Forward CAAAATTCGAGTGACAAGCCTG 113 bp
Reverse GAGATCCATGCCGTTGGC
NOS2 Forward CAGAGGACCCAGAGACAAGC 299 bp
Reverse TGCTGAAACATTTCCTGTGC
Cybb/NOX2 Forward GACTGCGGAGAGTTTGGAAG 258 bp
Reverse ACTGTCCCACCTCCATCTTG
Ncf1 Forward CGAGAAGAGTTCGGGAACAG 286 bp
Reverse AGCCATCCAGGAGCTTATGA
β-actin Forward CACCCTGTGCTGCTCACC 327 bp
Reverse GCACGATTTCCCTCTCAG
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Leica LAS AF software), where all imaged cells appear in
sharp focus. Individual retinas were sampled randomly to
collect a total of 20 images located at the same eccentricity
(1 to 1.5 mm from the optic disk) in the four retinal quad-
rants using a 20× objective. NeuN-positive neurons with
the size range of 6 to 30 μm were counted semi-
automatically using MetaMorph (Universal Imaging Co.)
software, after image thresholding and manual exclusion
of artifacts.
Statistical analysis
Statistical analysis of EAE clinical scores was carried out
with the Mann–Whitney test. Real-time PCR and cell
density data were analyzed with one-way ANOVA followed
by Tukey test for multiple comparisons. For single com-
parisons, Student’s t test was applied. P values ≤0.05 were
considered statistically significant.
Results
Inhibition of astroglial NF-κB protects the optic nerve
from loss of myelinated axons following experimental ON
In our previous studies with mice genetically modified to
suppress NF-κB activation specifically in astrocytes (GFAP-
IκBα-dn mice) we demonstrated that astrocyte-dependent
inflammatory cascades are key pathological contributors to
the development and progression of CNS trauma and dis-
ease, including EAE [14,15,17-19,22]. GFAP-IκBα-dn mice
exposed to MOG-induced EAE exhibited a significant
functional recovery compared to WT mice and this dir-
ectly correlated with the suppression of pro-inflammatory
mediators (chemokines, cytokines, adhesion molecules) in
the CNS [14]. Since ON is an early pathological feature of
MS and is typically observed in mice induced with EAE,
we sought to determine whether astrocyte-dependent
responses were involved in the pathophysiology of ON.
We subjected GFAP-IκBα-dn mice and WT littermates to
MOG-induced EAE as previously described [14], and
assessed myelin and axon damage in the optic nerve by
counting the number of PPD-stained myelinated axons at
various times post induction of the disease. GFAP-IκBα-dn
mice steadily recovered from EAE, contrary to WT mice
who exhibited chronic exacerbation of the symptoms
(Figure 1A), in agreement with our previously published
study [14]. In WT mice, loss of myelinated axons in the
optic nerve began as early as 5 days after induction of EAE
(Figure 1B, C), and reached statistical significance by 8 dpi
(Figure 1B, C), before the clinical motor symptoms of EAE
became evident (Figure 1A). The peak of axonal demyelin-
ation (about 68% reduction of the corresponding naïve
condition) was assessed at 11 dpi (Figure 1B, C), when only
minimal motor deficits were recorded (clinical score:
0.33±0.16; Figure 1A). No further loss was detected at
later time points, either acute (20 dpi) or chronic (40 dpi).
In striking contrast to WT mice, GFAP-IκBα-dn mice did
not exhibit any reduction in the number of myelinated
axons compared to naïve mice at all time points
(Figure 1B, C), showing complete protection. From 8 to 40
dpi, the numbers of myelinated axons were consistently
and significantly reduced in WT mice compared to trans-
genics, demonstrating that astrocyte-dependent cellular
events are key pathological determinants of the early stages
of ON.
Immune cell infiltration in the optic nerve occurs after
onset of axonal demyelination and is not affected by
inactivation of astroglial NF-κB
Since it has been suggested that axonal injury in ON is
due to the damaging effects of peripheral immune cells in-
filtrating into the optic nerve, we set out to investigate
whether the protection from axonal demyelination in
GFAP-IκBα-dn mice was dependent upon inhibition or
delay of immune cell infiltration. Leukocyte infiltration was
assessed by anti-CD45 immunohistochemistry on longitu-
dinal sections of the optic nerve collected at various time
points after induction of EAE (Figure 2). Interestingly, we
detected an identical pattern of infiltration in WT and
GFAP-IκBα-dn mice. Indeed, CD45+ cells were not present
at 5 dpi in both WT and GFAP-IκBα-dn mice (data not
shown), and virtually absent at 8 and 11 dpi, where only
very few isolated CD45+ leukocytes were observed in both
genotypes (Figure 2). The first appreciable numbers of in-
filtrating immune cells were detected at 20 dpi (Figure 2),
corresponding to the peak of EAE motor symptoms
(Figure 1A). Massive infiltration was evident at the chronic
time point of 40 dpi in both WT and GFAP-IκBα-dn mice
(Figure 2). These data convey two important points. First,
peripheral immune cell infiltration temporally occurs when
axonal demyelination in the optic nerve has already taken
place. Indeed, in WT mice a significant and robust reduc-
tion in the number of myelinated axons is detected at 8
dpi (Figure 1B, C), when essentially no infiltrating cells are
present (Figure 2). Second, GFAP-IκBα-dn mice are pro-
tected from axonal demyelination long term (40 dpi,
Figure 1B, C) despite the massive presence of infiltrating
leukocytes at later time points (40 dpi, Figure 2). Taken to-
gether these data demonstrate, for the first time, that optic
nerve demyelination is an early event in the pathophysi-
ology of ON and it is not secondary to immune cell infil-
tration and activation. Instead, the early demyelination is
dependent upon detrimental cascades initiated by resident
CNS cells, namely the astrocytes.
Inhibition of astroglial NF-κB suppresses the pro-
inflammatory response in the optic nerve following
experimental ON
We previously demonstrated that astrocyte-driven inflam-
mation is a key determinant of EAE pathophysiology. In-
deed, inhibition of the master regulator of inflammation
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NF-κB specifically in astrocytes in our GFAP-IκBα-dn mice
resulted in significant protection from EAE through the
suppression of pro-inflammatory gene expression in the
spinal cord and brain [14]. Having demonstrated that
GFAP-IκBα-dn mice induced with EAE are also protected
from optic nerve demyelination since the early stages of
Figure 1 Histological analysis and quantification of myelinated axons in the optic nerve of mice with ON. (A) Clinical course of
MOG(35–55)-induced EAE in WT and GFAP-IκBα-dn mice. EAE symptoms were scored daily for 60 days as described in Materials and Methods.
Results are expressed as the daily mean clinical score ± SEM of 24 animals/group from three independent experiments;*P< 0.0001, Mann–Whitney
test. (B) Histological analysis of PPD-stained, resin-embedded optic nerves of WT and GFAP-IκBα-dn mice under naïve conditions and at various
times after induction of EAE. Scale bar = 10 μm. (C) Quantification of the total number of myelinated axons in PPD-stained cross-sections of the
optic nerve using Stereoinvestigator software; ^P< 0.05 vs. WT naïve; *P< 0.05, one-way ANOVA, Tukey test. Ten mice/group were analyzed.
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ON (Figure 1), independently of any effect on peripheral
immune cell infiltration (Figure 2), we sought to determine
whether this could be correlated with a reduction in the
expression of pro-inflammatory mediators in the optic
nerve, similarly to what we observed in the other CNS
compartments previously investigated (spinal cord, brain)
[14]. We analyzed gene expression in the optic nerve in
naïve animals and at various time points after induction of
EAE, focusing on classical pro-inflammatory cytokines and
chemokines (TNF, IL1β, CXCL10, CCL5), adhesion mole-
cules (ICAM-1), and the nitric oxide signaling pathway
(NOS2). In WT mice we observed that the peak of gene
expression occurred at 11 dpi (Figure 3), coinciding tem-
porally with the peak of axonal demyelination (Figure 1C).
Importantly, inhibition of astroglial NF-κB in GFAP-IκBα-
dn mice resulted in a robust and significant suppression of
gene expression compared to WT mice. Specifically, upre-
gulation of IL1β, CXCL10, CCL5, and ICAM-1 were com-
pletely prevented. As for TNF, upregulation was
suppressed in GFAP-IκBα-dn mice compared to WT at 11
dpi but not at 20 dpi, the time point corresponding to the
peak of EAE motor symptoms, where the two genotypes
showed equal levels of TNF gene expression.
Inhibition of astroglial NF-κB suppresses the expression
of oxidative stress-related genes in the optic nerve
following experimental ON
In an effort to investigate multiple pathways potentially
involved in ON, we assessed the expression of oxidative
stress-related genes. First, we measured inducible nitric
oxide synthase (NOS2) and found, similarly to all other
genes we analyzed, that NOS2 was upregulated in WT
mice with a remarkable increase beginning at 11 dpi.
This upregulation, however, was almost fully suppressed
in GFAP-IκBα-dn mice (Figure 3).
Second, we evaluated the expression of two key com-
ponents of NAD(P)H oxidase, Cybb/NOX2 (encoding
for gp91phox, the catalytic subunit of the complex) and
Ncf1 (encoding for p47phox, the regulatory subunit of the
complex). Excessive production of reactive oxygen spe-
cies via NAD(P)H oxidase has been associated with
neurological disease [24]. Recently, using the same
GFAP-IκBα-dn mice employed in the present study, we
demonstrated that NF-κB-regulated NAD(P)H oxidase
in astrocytes is a crucial mediator of oxidative stress in a
model of retinal ischemia and inhibition of its activity
reduces damage by preventing RGC loss [25]. We found
Cybb/NOX2 to be highly upregulated in WT mice at 11
dpi and this effect was fully abrogated in GFAP-IκBα-dn
mice (Figure 4A). Interestingly, Cybb/NOX2 was signifi-
cantly lower under naïve conditions in GFAP-IκBα-dn
mice compared to WT, suggesting that transgenic mice
may have an intrinsically reduced ability to generate
ROS through NAD(P)H oxidase, hence a higher protec-
tion against oxidative stress. The upregulation of the
Ncf1 subunit was also completely prevented in GFAP-
IκBα-dn mice, further suggesting a reduced functionality
of the NAD(P)H oxidase complex (Figure 4A). Consist-
ently with the gene expression data, we found that
p47phox protein expression was upregulated in WT optic
Figure 2 Leukocyte infiltration in the optic nerve of mice with ON. Double immunohistochemistry for the astrocyte-specific marker GFAP
(red) and the pan-leukocyte marker CD45 (green) in 10-μm thick cryostat-cut sections of the optic nerve of WT and GFAP-IκBα-dn mice under
naïve conditions and at various times after induction of EAE. Nuclei were labeled with DAPI. White arrows: isolated CD45+ leukocytes. Scale
bar = 20 μm.
Brambilla et al. Journal of Neuroinflammation 2012, 9:213 Page 6 of 12
http://www.jneuroinflammation.com/content/9/1/213
nerves compared to GFAP-IκBα-dn, with the highest
level of expression at 11 dpi (Figure 4B). Double
immuno-labeling with GFAP indicated that p47phox is
primarily localized to astrocytes, suggesting that astro-
glial NF-κB is a key transcriptional regulator of this mol-
ecule in the optic nerve.
Collectively, these data suggest that astrocyte may con-
tribute to the early pathological events of ON through
the production of oxidative species which, in parallel with
other inflammatory mediators, could be causing myelin
and axon damage.
Inhibition of astroglial NF-κB significantly reduces RGC
loss
Permanent damage of visual function in ON comes as a
consequence of Wallerian degeneration of the optic nerve
which ultimately leads to delayed death of RGCs [2,3].
Therefore, to assess the extent of irreversible visual dam-
age, we evaluated RGC survival in WT and GFAP-IκBα-
dn mice at various times after induction of EAE. Retinal
whole mounts were immuno-labeled with the pan-
neuronal marker NeuN and RGCs in the ganglion cell
layer were counted.
In WT mice, we detected a minimal loss of RGCs at 20
dpi, which became significant only at 40 dpi, when com-
pared to naïve mice. No significant loss of RGCs was
detected in GFAP-IκBα-dn mice at these time points
(Figure 5 A, B). A substantial loss of RGCs (about 60% of
naïve) was detected in WT mice at the late chronic phase
at 80 dpi, while the rate was significantly reduced (below
40%) in GFAP-IκBα-dn mice at corresponding time point
(Figure 5B). This further underscores that astrocytes play a
significant pathological role in the development of neuro-
logical deficits in ON, and blocking astrocyte-dependent
detrimental cascades can almost fully protect from visual
dysfunction associated with EAE.
Discussion
This study provides evidence that astrocytes play a key role
in the development of ON. This occurs through the activa-
tion of a transcriptional program regulated by NF-κB. In-
deed, using a well characterized transgenic mouse model
where NF-κB is specifically inactivated in astrocytes
(GFAP-IκBα-dn mice), we show that NF-κB-dependent
events initiated in astrocytes establish an environment that
facilitates early axonal demyelination which takes place
well ahead of leukocyte infiltration into the optic nerve.
Figure 3 Pro-inflammatory gene expression in the optic nerve of mice with ON. Gene expression was assessed in naïve animals and at 8,
11, and 20 dpi. For each gene, results were expressed as fold of corresponding WT naive ± SEM after normalization to β-actin. Four animals/
group/time were analyzed. *P< 0.05, one-way ANOVA, Tukey test.
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These data challenge the paradigm that ON is triggered by
inflammatory events secondary to immune cell infiltration,
and demonstrate that axonal demyelination in ON is, in-
stead, an extremely early event driven by detrimental
astrocyte-dependent effects. Our findings in ON are con-
sistent with the pathological role that astrocytes play, as
initiators of inflammation and oxidative stress, in many
neurodegenerative diseases, as demonstrated by work of
our and other laboratories [14,15,17-20,25-27].
Activation of an NF-κB-regulated program in astrocytes is
associated with early demyelination
Previous studies have reported axonal demyelination to
coincide with blood-borne cell entry into the optic nerve
parenchyma, suggesting that ON is triggered by immune-
mediated events secondary to leukocyte infiltration
[6,28,29]. Unexpectedly and in contrast with this largely
accepted concept, our experiments in WT mice induced
with EAE showed the appearance of significant myelin
Figure 4 Expression of the NAD(P)H oxidase subunits Cybb/NOX2 (gp91phox) and Ncf1 (p47phox) in the optic nerve of mice with ON.
(A) Gene expression was assessed in naïve animals and at 8 and 11 dpi. For each gene, results were expressed as fold of corresponding WT
naive ± SEM after normalization to β-actin. Four mice/group/time were analyzed. *P< 0.05, one-way ANOVA, Tukey test. (B) p47phox
immunohistochemistry in the optic nerve of WT and GFAP-IκBα-dn mice in naïve conditions and at 11 and 20 dpi. Arrows point at astrocytes
colocalizing with p47phox protein. Yellow arrows identify the cells magnified in the inserts. Scale bar = 20 μm.
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damage several days prior to the earliest signs of infiltra-
tion. We conducted a thorough time-course analysis of
demyelination beginning as early as 5 dpi, and found that
from 8 to 40 dpi, the numbers of myelinated axons were
consistently and significantly reduced in WT mice. Con-
versely, GFAP-IκBα-dn mice were completely protected
from axonal demyelination even at chronic time points
after induction of EAE. The assessment of leukocyte infil-
tration conducted in parallel to the analysis of demyelin-
ation clearly underscored two major points: first, immune
cell infiltration, as measured by CD45 immunohistochem-
istry, occurs after optic nerve demyelination reaches its
peak (11 dpi); second, the extent and timing of immune
cell infiltration is independent of astroglial NF-κB inactiva-
tion. In support of the latter, both WT and GFAP-IκBα-dn
mice show similar profiles of CD45+ infiltrating cells at all
time points evaluated. These data demonstrate that
astroglial- rather than immune cell-dependent events are
the key pathological determinants of the early stages of
myelin loss in ON and challenge the established paradigm
that infiltration of CD45+ cells is required for the onset of
this pathology. Indeed, our data show that immune cells
are virtually absent at the onset of ON, suggesting that
most of the damage is facilitated by local rather than infil-
trating cells. Nevertheless, we cannot exclude that low
numbers of such sporadic infiltrating cells may still play a
role at this stage. On the other hand, it is likely that
leukocyte-dependent inflammation may contribute to optic
nerve damage at later times, given the overwhelming pres-
ence of such cells in both genotypes at chronic disease (40
dpi). It is also worth pointing out that optic nerve demye-
lination is a pathological occurrence that precedes any
manifestation of EAE-induced motor impairment, which
initiates around day 10 and reaches peak around day 20
post induction (Figure 1A). This correlates with the human
pathology where acute ON causing temporary visual
impairment is often the earliest manifestation of MS, lead-
ing up to the initial diagnosis of the disease [1].
Activation of NF-κB-dependent pathways in astrocytes
sustains the inflammatory response in the optic nerve
Neuroinflammation and oxidative stress are two of the
major culprits of CNS damage in MS and EAE [30-32].
Studies from our and other groups have shown that
these processes are linked to the contribution of the
astrocytes, either direct or indirect, and their ability to
secrete toxic mediators which sustain and propagate
CNS damage [14,26]. Indeed, using the same GFAP-
IκBα-dn mice employed in this study, we previously
showed that activation of NF-κB in astrocytes promotes
the expression of pro-inflammatory cytokines and che-
mokines in the spinal cord of EAE-induced mice and
suppression of this process via transgenic inhibition of
astroglial NF-κB leads to functional recovery [14]. Simi-
larly, in a mouse model of CNS-restricted NF-κB inacti-
vation, van Loo and colleagues demonstrated that NF-κB
inhibition prevented the expression of pro-inflammatory
cytokines, chemokines, and the adhesion molecule
VCAM-1 from astrocytes, suggesting that NF-κB-
dependent gene expression in CNS resident cells creates
a pro-inflammatory milieu that is critical for CNS in-
flammation and tissue damage in autoimmune demye-
linating disease [26]. In agreement with these studies,
our current work indicates that pathways downstream of
astroglial NF-κB activation are key regulators/effectors
of astroglia-induced neurotoxicity in ON as well. Specif-
ically, we found that upregulation of IL1β, CXCL10,
CCL5, and ICAM-1 was completely suppressed in the
optic nerve of GFAP-IκBα-dn animals compared to WT.
This is consistent with the fact that these molecules are
massively produced by activated astrocytes and are tran-
scriptionally regulated by NF-κB. The expression of TNF
was more robust in WT versus GFAP-IκBα-dn at 11 dpi,
but reached equal levels at 20 dpi, the time correspond-
ing to the peak of EAE motor symptoms. This may be
explained by the fact that, in contrast to the production
of IL1β, CXCL10 and CCL5, microglia rather than
Figure 5 Time-course of RGC loss in mice with ON. (A) Immunohistochemistry with the pan-neuronal marker NeuN in flat-mounted retinas of
WT and GFAP-IκBα-dn mice under naïve conditions and at various times after induction of EAE. (B) Quantification of NeuN-labeled RGCs with
MetaMorph software. *P< 0.05, one-way ANOVA, Tukey test. Ten mice/group were analyzed. Scale bar = 50 μm.
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astrocytes are the main cellular source of TNF in the
injured CNS [14,33]. It is also important to notice that
microglial cells are not affected by NF-κB functional
inhibition in GFAP-IκBα-dn mice. Furthermore, TNF is
highly produced by macrophages and T cells and this
could be reflected in the peak of TNF expression at 20
dpi, when immune cell infiltration was found to be more
abundant (Figure 2). Cell adhesion molecules are critical
for immune cell activation and trafficking across the
blood–brain barrier (BBB) into the CNS parenchyma
[34]. We found that peak expression of ICAM-1, which
occurred in WT mice at 11 dpi, was completely abro-
gated in GFAP-IκBα-dn mice (Figure 3). Because ICAM-
1 is expressed by astrocytes and is one of the prototyp-
ical NF-κB-dependent genes [35,36], this may suggest
that astrocytes can facilitate immune cell entry into the
optic nerve, hence sustaining immune-inflammation
occurring at the later stages of the disease (Figure 2).
It is important to emphasize that, albeit minimal, the
first signs of demyelination were already noticeable as
soon as 5 dpi (Figure 1B, C), the time point where
massive changes in gene expression are not yet detect-
able. This suggests that early astrocyte-regulated signals
are participating in the very initial stages of ON induc-
tion, acting in parallel to the above mentioned pro-
inflammatory mediators and perhaps independently of
de novo gene expression. Multiple injury mechanisms
might be involved, including an increased production of
nitric oxide (NO) or excitotoxic levels of glutamate,
which can be produced by activated white-matter astro-
cytes. Both elevated NO and glutamate were shown to
be responsible for reduced energy metabolism, and cause
axonal damage [37]. Although a significant increase in
expression of the Nos2 gene was evident by 11 dpi, activ-
ity levels of the corresponding enzyme or extracellular
glutamate concentrations were not assessed in this
study. Based on the elevated levels of glutamate and NO
in the normal appearing white matter of MS patients,
one of the current hypotheses is that axonal mitochon-
drial energy failure may lead to axonal degeneration in
MS [38,39]. These putative mechanisms are currently
under investigation in the laboratory.
Activation of NF-κB-dependent pathways in astrocytes
sustains the oxidative stress response in the optic nerve
In an effort to investigate multiple neurotoxic pathways
potentially involved in ON, we assessed the levels of
NOS2 and superoxide producing phagocytic NAD(P)H
oxidase. Activation of these enzymes is known to cause
oxidative damage to myelin and axons through the pro-
duction of nitric oxide and superoxide, which can fur-
ther react to produce the strong oxidant peroxynitrite
[40]. We found, similarly to all other genes we analyzed,
that NOS2 and the NAD(P)H oxidase subunits Cybb/
NOX2 and Ncf1 were upregulated in WT mice beginning
at 11 dpi, but not in GFAP-IκBα-dn mice, suggesting that
astrocyte may contribute to the early pathological events
of ON through the production of reactive oxygen species.
These results are consistent with our previous observa-
tions in a model of retinal ischemia-reperfusion where we
showed that oxidative stress and neuronal loss in the ret-
ina depend on NF-κB-regulated activation of Cybb/
NOX2 in astrocytes [25]. Other groups have also demon-
strated that astrocyte-mediated oxidative stress is a key
factor in optic nerve damage. Fitzgerald and colleagues
have shown that oxidative stress spreading via the astro-
cytic network is an early event during secondary degener-
ation, and containment of this phenomenon is required
in order to prevent further damage to the nerve [41].
Astrocyte-mediated toxicity contributes to RGC loss
In MS/EAE-associated optic neuritis RGCs die retro-
gradely following axonal injury. Consistent with numer-
ous reports that show axonal injury and demyelination
to precede RGC death, our data also indicate that RGC
loss is secondary to optic nerve damage. The fact that
GFAP-IκBα-dn were significantly protected from RGC
death compared to WT mice is a further demonstration
that toxic pathways activated in astrocytes are the initial
determinant in the cascade of events leading, ultimately,
to permanent loss of visual function in optic neuritis.
Because the protection from RGC loss was not complete,
it is reasonable to believe that other mechanisms, in
addition to astrocyte-mediated events, may be responsible
for RGC death. One possibility is that leukocytes infiltrat-
ing the optic nerve at later times, as we show in our
CD45 immunostaining, may produce inflammatory mole-
cules that can cause axonal damage and consequently
RGC death. These events are not prevented by blocking
astrocytic NF-κB and could account for the lack of full
RGC protection seen in GFAP-IκBα-dn mice.
Conclusions
In conclusion, our results provide evidence that astro-
cytes play a key role in the development of optic neuritis
secondary to MOG-induced EAE. Astrocyte-mediated
neurotoxicity is dependent on activation of a transcrip-
tional program regulated by NF-κB. Importantly, our
data point out that axonal demyelination is already
severe early, in the pre-clinical phase, when upregulation
of pro-inflammatory and oxidative stress-related genes
and accumulation of their products is not yet significant.
These results suggest that pro-inflammatory and reactive
oxygen species are not likely to serve as the initial trig-
gers of demyelination, despite such molecules may
greatly contribute to the damage during acute disease.
Other NF-κB-dependent events activated in astrocytes at
very early stages of the disease must be implicated in the
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initiation of ON and are the main focus of our ongoing
investigations. Our studies underscore that interventions
specifically targeting the NF-κB transcription factor in
astroglia may be of therapeutic value in the treatment of
optic neuritis associated with multiple sclerosis.
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